NasdaqGS - Delayed Quote • USD
Amgen Inc. (AMGN)
At close: May 17 at 4:00 PM EDT
After hours: May 17 at 7:28 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 21 | 21 | 25 | 24 |
| Avg. Estimate | 4.97 | 5.17 | 19.44 | 20.44 |
| Low Estimate | 4.46 | 4.81 | 19.08 | 18.18 |
| High Estimate | 5.43 | 5.51 | 20.09 | 23.33 |
| Year Ago EPS | 5 | 4.96 | 17.42 | 19.44 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 20 | 19 | 25 | 25 |
| Avg. Estimate | 8.31B | 8.44B | 33.01B | 33.93B |
| Low Estimate | 8.13B | 8.29B | 32.58B | 32B |
| High Estimate | 8.63B | 8.62B | 33.88B | 35.92B |
| Year Ago Sales | 6.99B | 6.9B | 26.34B | 33.01B |
| Sales Growth (year/est) | 18.90% | 22.20% | 25.40% | 2.80% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 4.49 | 4.67 | 4.3 | 3.87 |
| EPS Actual | 5 | 4.96 | 4.4 | 3.96 |
| Difference | 0.51 | 0.29 | 0.1 | 0.09 |
| Surprise % | 11.40% | 6.20% | 2.30% | 2.30% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 4.97 | 5.17 | 19.44 | 20.44 |
| 7 Days Ago | 4.97 | 5.17 | 19.45 | 20.41 |
| 30 Days Ago | 4.68 | 4.92 | 18.39 | 19.82 |
| 60 Days Ago | 4.99 | 5.22 | 19.57 | 21.12 |
| 90 Days Ago | 4.98 | 5.22 | 19.58 | 21.19 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | 11 | 8 | 12 | 9 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| CURRENCY IN USD | AMGN | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -0.60% | -- | -- | 8.00% |
| Next Qtr. | 4.20% | -- | -- | 12.40% |
| Current Year | 11.60% | -- | -- | 5.60% |
| Next Year | 5.10% | -- | -- | 13.00% |
| Next 5 Years (per annum) | 5.72% | -- | -- | 11.14% |
| Past 5 Years (per annum) | 4.22% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Mizuho: Neutral to Neutral | 5/9/2024 |
| Maintains | RBC Capital: Outperform to Outperform | 5/3/2024 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 5/3/2024 |
| Maintains | UBS: Neutral to Neutral | 5/3/2024 |
| Upgrade | William Blair: Market Perform to Outperform | 5/3/2024 |
| Maintains | BMO Capital: Outperform to Outperform | 5/3/2024 |
Related Tickers
MRK Merck & Co., Inc.
131.19
+0.24%
ABBV AbbVie Inc.
166.42
+1.26%
LLY Eli Lilly and Company
770.00
-0.15%
GILD Gilead Sciences, Inc.
67.72
-0.21%
BMY Bristol-Myers Squibb Company
44.03
-0.18%
JNJ Johnson & Johnson
154.64
+0.23%
BIIB Biogen Inc.
230.57
+0.23%
PFE Pfizer Inc.
28.64
-0.97%
AZN AstraZeneca PLC
76.90
-0.18%
NVS Novartis AG
102.57
-0.12%